[1]
Hrynkiv , Y. and Boiko , T. 2026. Cost of migraine attack control: comparative characteristics of rizatriptan preparations on the pharmaceutical market of Ukraine. Annals of Mechnikov’s Institute. 2 (May 2026), 111–117. DOI:https://doi.org/10.5281/zenodo.20005004.